A diagnostic system called the DNA Endonuclease Targeted CRISPR Trans Reporter, or DETECTR, could make possible quick and easy point-of-care detection of even small amounts of DNA in clinical samples. Using DETECTR, scientists were able to demonstrate accurate detection of the “high-risk” HPV types 16 and 18 in samples infected with many different HPV types, and it could possibly help detect cancer.